Atlas Trials

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Clinical trial NCT06208410 · RECRUITING

Trial details

NCT number
NCT06208410
Sponsor
Risen (Suzhou) Pharma Tech Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2024-01-11
Primary completion
2027-02-26
Enrollment
306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.